Search filters

List of works by Bertrand Routy

Anticancer effects of the microbiome and its products

scientific article published on 22 May 2017

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

scientific article published on 5 November 2015

COVID-19: a challenge for oncology services

scientific article published on 05 May 2020

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

scientific article published on 25 May 2020

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

scientific article published on 01 August 2020

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

scientific article published on 20 July 2020

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

scientific article

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

scientific article published on 2 November 2017

Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients

scientific article published on 01 December 2020

Immunodynamics of explanted human tumors for immuno-oncology

scientific article published on 29 December 2020

Immunological off-target effects of imatinib

scientific article

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

scientific article published on 07 May 2021

Microbiome and Anticancer Immunosurveillance

scientific article

Prime time for immune-checkpoint targeted therapy at ASCO 2015

scientific article

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

scientific article published on 06 July 2021

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

scientific article published on June 2016

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer

scientific article published on 11 October 2017

The gut microbiota influences anticancer immunosurveillance and general health

scientific article published on 10 April 2018

The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1

scholarly article by Lisa Derosa et al published 2018 in OncoImmunology

The intimate relationship between gut microbiota and cancer immunotherapy

scholarly article by Arielle Elkrief et al published 19 October 2018 in Gut microbes

Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

scientific article published on 03 June 2020